Clinical trial
ClearSight NextGen System Clinical Development Study
NCT07317648 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ClearSight NextGen System Clinical Development Study
- Lead sponsor
- Becton, Dickinson and Company
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 16, 2025
- Completion date
- March 5, 2026
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure